Compound dermatophytosis treatment liquid medicine and preparation method thereof

A technology of liquid medicine and beriberi, which is applied in the direction of medical formula, drug combination, drug delivery, etc., can solve the problems of easy recurrence, cumbersome use, and long treatment cycle, and achieve the effect of non-toxic side effects, unique compatibility, and remarkable effect

Active Publication Date: 2012-07-04
SHANGHAI YAOJIAN BIO TECH
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to very complicated reasons, the therapeutic effect of these drugs is not satisfactory
Moreover, the treatment cycle is long, the use (taking) is cumbersome, the compliance is poor, and it is easy to relapse, especially many drugs have obvious toxic side effects on the liver and kidney.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound dermatophytosis treatment liquid medicine and preparation method thereof
  • Compound dermatophytosis treatment liquid medicine and preparation method thereof
  • Compound dermatophytosis treatment liquid medicine and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0088] Such as figure 1 The preparation method of the medicinal liquid of compound prescription treatment beriberi of the present invention, its steps are as follows:

[0089] (1) Dissolve nano silver, polyhexamethylene guanidine and benzalkonium chloride in medical purified water;

[0090] (2) Dissolving the auxiliary material menthol in glacial acetic acid;

[0091] (3) Dissolve the solution of (2) with propylene glycol, citric acid, lactic acid, alkyl glucoside, cocoyl glyceride and other excipients of mint flavor in the above-mentioned added nano silver, polyhexamethylene guanidine, benzalkonium chloride In aqueous ammonium solution;

[0092] (4) Stir at the same time, after stirring evenly, filter and fill to obtain the compound medicinal liquid for treating beriberi.

[0093] Equipment requirements:

[0094] Reactor: stainless steel reactor

[0095] Filter: yarn core filter (aperture 0.1-0.4um)

[0096] Environmental requirements:

[0097] Adopt 100,000-level air ...

Embodiment 1

[0100] In the present embodiment, a kind of compound medicine liquid for treating beriberi contains the following components by weight percentage:

[0101] Nanosilver 0.1%

[0102] Polyhexamethyleneguanidine 0.005%

[0103] Benzalkonium Chloride 2.5%

[0104] Glacial acetic acid 5%

[0105] Menthol 0.005%

[0106] Glycerin 0.1%

[0107] Citric Acid 2.5%

[0108] Lactic Acid 2.5%

[0109] Alkyl Glycoside 0.01%

[0110] Coco Glycerides 0.01%

[0111] Purified water for medical use and the rest.

Embodiment 2

[0113] In the present embodiment, a kind of compound medicine liquid for treating beriberi contains the following components by weight percentage:

[0114] Nano Silver 1%

[0115] Polyhexamethyleneguanidine 0.75%

[0116] Benzalkonium Chloride 1.5%

[0117] Glacial acetic acid 8%

[0118] Menthol 0.05%

[0119] Sorbitol 0.5%

[0120] Citric Acid 1.5%

[0121] Lactic Acid 1.5%

[0122] Alkyl Glycosides 0.5%

[0123] Coco Glycerides 0.5%

[0124] Purified water for medical use and the rest.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses compound dermatophytosis treatment liquid medicine, which comprises antibacterial ingredients, wherein the antibacterial ingredients comprise nanometer sliver, polyhexamethylene guanide, benzalkonium chloride, glacial acetic acid and the like. The compound dermatophytosis treatment liquid medicine comprises the following ingredients in percentage by weight: 0.1 to 2 percent of nanometer sliver, 0.005 to 1 percent of polyhexamethylene guanide, 0.01 to 2.5 percent of benzalkonium chloride, 5 to 30 percent of glacial acetic acid, 0.005 to 0.5 percent of menthol, 0.01 to 2.5 percent of citric acid, 0.01 to 2.5 percent of lactic acid, 0.1 to 2 percent of humectants, 0.01 to 2 percent of alkyl polyglucoside, 0.01 to 2 percent of coconut oil base glyceride and the balanceof medical purified water. The invention also provides a unique liquid medicine preparation method. Compared with the prior art, the compound dermatophytosis treatment liquid medicine and the preparation method provided by the invention have the advantages that the compatibility of medicines is unique, the once treatment effect is obvious and durable, the recurrence rate is low, and no toxic or side effect exists.

Description

technical field [0001] The invention relates to a medicine and a preparation method thereof, in particular to a medicine liquid for treating beriberi and a treatment method thereof. Background technique [0002] Beriberi claims again tinea pedis, is a kind of common disease, frequently-occurring disease. According to epidemiological surveys, as many as 70% of adults suffer from the disease to varying degrees. Therefore, beriberi is seriously affecting the health, work, study and advocating life of the masses. [0003] At present, there are many medicines for treating beriberi, such as various ointments such as ketoconazole, oral terbinafine and itraconazole, and other creams, liniments, foot baths, etc. However, due to very complicated reasons, the therapeutic effect of these drugs is not satisfactory. Moreover, the treatment cycle is long, the use (taking) is cumbersome, the compliance is poor, and it is easy to relapse, especially many drugs have obvious toxic and side ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K33/38A61K9/08A61P17/00A61P31/10A61K31/14A61K31/19A61K31/785
Inventor 王井光刘传伟
Owner SHANGHAI YAOJIAN BIO TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap